Pulse Explorar nav.journalClub Debates Tendências Pesquisadores Revistas

Início Explorar nav.journalClub Tendências

⌘+K

Disparities in Prescription of Long-Acting GLP-1s. | Synapse

March 5, 20260 citations

Disparities in Prescription of Long-Acting GLP-1s.

View Full Paper

KWKatherine WasdenBrigham and Women's Hospital NSNora O. SheuBrigham and Women's Hospital PMPourya MedhatiBrigham and Women's Hospital

Key Points

The study aims to analyze the disparities in the prescription of long-acting GLP-1 medications, focusing on racial and ethnic differences.
Analyzed prescription data among various racial and ethnic groups.
Examined the impact of private insurance and established patient relationships.
Investigated changes in prescription patterns post-Medicaid policy modifications.
Black and Hispanic patients were prescribed GLP-1s less often.
Patients with private insurance and established relationships showed higher prescription rates.
Disparities in medication prescriptions lessened following the Medicaid policy change.

Abstract

Black and Hispanic patients were less likely and patients with private insurance, diabetes, and established patient relationships were more likely to be prescribed Sema/Tirz. Racial and ethnic disparities in medication prescription were less apparent after a state Medicaid policy change to cover new GLP-1s.

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Wasden et al. (Mon,) studied this question.

synapsesocial.com/papers/69a91e65d6127c7a504c268e https://doi.org/https://doi.org/10.1002/oby.70152

Perguntar à IA

Like

Bookmark

Share

View Full Paper